Pasadena Urological Med Group is categorized under Urologists in Pasadena, CA and active since 1930.
Pasadena Urological Med Group was established in 1930, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Urologists business, which does work in the B2C market, and is classified as a Urologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Sheri Stadelhofer, Office Manager at the company’s single location by writing to 112 North Madison Avenue, Pasadena, California CA 91101 or by phoning (626) 796-8102. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pasadena Urological Med Group |
Contact Person: | Sheri Stadelhofer, Office Manager |
Address: | 112 North Madison Avenue, Pasadena, California 91101 |
Phone Number: | (626) 796-8102 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1930 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Urologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Pasadena Urological Med Group was started in 1930 to provide professional Urologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Sheri Stadelhofer, Office Manager for inquiries that concern Pasadena Urological Med Group by calling the company number (626) 796-8102, as your correspondence is most welcome. Additionally, the physical location of the single location of Pasadena Urological Med Group can be found at the coordinates 34.1481,-118.13834 as well as the street address 112 North Madison Avenue in Pasadena, California 91101.
For its online presence, you may visit Pasadena Urological Med Group’s website at and engage with its social media outlets through on Twitter and on Facebook.